Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand

  1. Home

  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    (0283–0307) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster I
    Location: Poster Hall
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0283: Transcriptomic Profiles in Muscle Biopsies from Systemic Sclerosis Patients with Different Autoantibodies
    Location: Poster Hall
    Abstract Poster Presenter: Maria Casal-Dominguez, MD, PhD – NIAMS, NIH
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0284: Phenotyping Calcinosis: A Rare Manifestation of Rare Diseases
    Location: Poster Hall
    Abstract Poster Presenter: Marta Mosca, MD, PhD – University of Pisa
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0285: Patient Reported Physical Function, Mental Health, and Treatment Patterns in Dermatomyositis
    Location: Poster Hall
    Abstract Poster Presenter: Lisa Christopher-Stine, MD, MPH – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0286: Relationship Between High Resolution Computed Tomography(HRCT) Quantitative Scores and Physiological and Clinical Features in Antisynthetase Syndrome Related Interstitial Lung Disease
    Location: Poster Hall
    Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0287: 6-Minute Walk Distance Associates with Physiologic Measures and Physician/Patient Reported Outcomes in Myositis Related Interstitial Lung Disease
    Location: Poster Hall
    Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0288: Proinflammatory Bioactive Lipid Mediators (BLM) Are Associated with Worse Anti-Oxidant Function of High Density Lipoproteins (HDL) in Patients with Idiopathic Inflammatory Myopathies (IIM)
    Location: Poster Hall
    Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0289: Markers of Endothelial Damage Are Elevated in Patients with Dermatomyositis Associated Interstitial Lung Disease and Associated with Low Paraoxonase-1 Activity
    Location: Poster Hall
    Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0290: Patient-reported Quality of Life and Working Status Outcomes in Ambulatory Patients with Idiopathic Inflammatory Myopathy
    Location: Poster Hall
    Abstract Poster Presenter: Zhao Peng, MD – Peking Union Medical College Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0291: Myopathy Related to Small-to-medium-sized Vessel Vasculitis: Immunopathological Characteristics
    Location: Poster Hall
    Abstract Poster Presenter: Shun Nomura, MD (he/him/his) – Shinshu University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0292: Comparison of Cardiovascular Risk of Myositis Patients and the General Population
    Location: Poster Hall
    Abstract Poster Presenter: Michal Tomcik, MD, PhD – Institute of Rheumatology
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0293: Characteristics and Outcomes of Idiopathic Inflammatory Myositis Associated Interstitial Lung Disease in Rural Appalachia
    Location: Poster Hall
    Abstract Poster Presenter: FNU Rida Ul Jannat, MD – West Virginia University Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0294: Tofacitinib Treatment in Rheumatoid Arthritis Is Associated with Increased Lower Limb Muscle Volume: The Rheumatoid Arthritis and Muscle (RAMUS) Study
    Location: Poster Hall
    Abstract Poster Presenter: Joshua Bennett, MBBS – Newcastle University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0295: Pneumocystis Jirovecii Pneumonia in Patients with Inflammatory Myopathies
    Location: Poster Hall
    Abstract Poster Presenter: Cody Bruggemeyer, MD – Medical College of Wisconsin
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0296: Does Presence of Anti-SSa and Ro52 Influence the Progression of Interstitial Lung Disease (ILD) in Idiopathic Inflammatory Myopathies (IIM)
    Location: Poster Hall
    Abstract Poster Presenter: Sonali Narain, MD, MPH – Northwell Health
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0297: Characteristics of Anti-MDA-5 Associated Dermatomyositis in Southern California with a Large Hispanic Population: Case Series
    Location: Poster Hall
    Abstract Poster Presenter: Eaman Alhassan, MD (she/her/hers) – University of Southern California
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0298: Accuracy of the 2017 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) Classification Criteria and Myositis-Specific Autoantibodies-Based Classification Criteria for Classifying Patients with Idiopathic Inflammatory Myopathy
    Location: Poster Hall
    Abstract Poster Presenter: Marta Domínguez, PhD – Sociedad Española de Reumatología
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0299: Trends and Outcomes of Hospitalized Patients with Idiopathic Inflammatory Myopathy and Venous Thromboembolism: A Nationwide Inpatient Sample Analysis from US (2016-2019)
    Location: Poster Hall
    Abstract Poster Presenter: Haseeb Chaudhary, MD – Case Western Reserve University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0300: Nailfold Videocapillaroscopy in Idiopathic Inflammatory Myopathy Compared with Healthy Controls
    Location: Poster Hall
    Abstract Poster Presenter: Megan Sullivan, MD – Mayo Clinic Arizona
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0301: Inflammatory Myopathies and Their Relationship with Cancer in a Colombian Cohort
    Location: Poster Hall
    Abstract Poster Presenter: David Aguirre-Valencia – Fundación Valle del Lili
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0302: Remission in Anti-HMGCR Positive Immune-mediated Necrotizing Myopathy Without the Use of Glucocorticoids: A Multicentric Study of 24 Patients
    Location: Poster Hall
    Abstract Poster Presenter: Cristina Corrales, MD (she/her/hers) – HOSPITAL UNIVERSITARIO MARQUES DE VALDECILLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0303: Development of a Human Cytotoxic Myoinjury Model with CD8+ T Cells and Muscle Cells Differentiated from Human Induced Pluripotent Stem Cells
    Location: Poster Hall
    Abstract Poster Presenter: Hisanori Hasegawa, MD, PhD – Tokyo Medical and Dental University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0304: Incidence of Disease Flares Following COVID-19 Vaccination in a Diverse Idiopathic Inflammatory Myopathy Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Hillary Weisleder, MD – Montefiore Einstein
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0305: Prevalence and Clinical Significance of anti-Ro52 Antibodies in Antisynthetase Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Javier Narvaez, MD, PhD – Hospital Universitario de Bellvitge
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0306: Fitbit Is a Valid and Reliable Physical Activity Monitor in Idiopathic Inflammatory Myopathy
    Location: Poster Hall
    Abstract Poster Presenter: Akanksha Sharma, MD – UPMC Mercy hospital, Pittsburgh, PA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    9:00 AM – 11:00 AM PT
    0307: Long-term Prognosis and Recurrence in anti-MDA-5 Antibody-positive Dermatomyositis
    Location: Poster Hall
    Abstract Poster Presenter: Jun Nakamura, MD, PhD – Jichi Medical University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    12:00 PM – 1:00 PM PT
    12S129: Palliative Care: Is It Time to Make “Rheum” for This?
    Location: Room 24A-C
    Moderator: Kamini Kuchinad, MD, MPH – Johns Hopkins University
    Moderator: Jemima Albayda, MD, RhMSUS – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME: 1 hours
  • Sunday, Nov 12th
    12:00 PM – 12:15 PM PT
    The What, Why, and How of Palliative Care
    Location: Room 24A-C
    Speaker: David Wu, MD – Johns Hopkins Bayview Medical Center / Johns Hopkins School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    12:15 PM – 12:30 PM PT
    Neuropalliative Care: Lessons We Can Learn from Our Neurology Colleagues
    Location: Room 24A-C
    Speaker: Ambereen Mehta, MD, MPH – Johns Hopkins School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    12:30 PM – 12:45 PM PT
    I Can't Breathe: Palliative Care for Lung Disease
    Location: Room 24A-C
    Speaker: Donald Sullivan, MD, MA – none
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    12:45 PM – 1:00 PM PT
    Q&A
    Location: Room 24A-C
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    2:00 PM – 3:00 PM PT
    12S138: Meet the Panel: Challenging Cases in Adult and Juvenile Myositis
    Location: Room 29A-D
    Moderator: Galina Marder, MD – Donald and Barbara Zucker School of Medicine at Hofstra/ Northwell
    Moderator: Lesley Ann Saketkoo, MD, MPH – University Medical Center - Comprehensive Pulmonary Hypertension Center and ILD Clinic Programs // New Orleans Scleroderma and Sarcoidosis Patient Care & Research Centeris
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME: 1 hours
  • Sunday, Nov 12th
    2:00 PM – 2:45 PM PT
    Meet the Panel: Challenging Cases in Adult and Juvenile Myositis
    Location: Room 29A-D
    Panelist: Chester Oddis, MD – University of Pittsburgh
    Panelist: Lisa Rider, MD – NIEHS, NIH
    Panelist: Susan Shenoi, MS, MBBS, RhMSUS – Seattle Childrens Hospital
    Panelist: Victoria Werth, MD – University of Pennsylvania
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Sunday, Nov 12th
    2:45 PM – 3:00 PM PT
    Q&A
    Location: Room 29A-D
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    (1155–1182) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster II
    Location: Poster Hall
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1155: Identification of Serum Biomarkers Associated with Muscle Damage Detected on MRI in Polymyositis/dermatomyositis
    Location: Poster Hall
    Abstract Poster Presenter: Haruna Matsuo, MD – Nagasaki University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1156: Presentations and Outcomes of Idiopathic Inflammatory Myopathies in Hong Kong
    Location: Poster Hall
    Abstract Poster Presenter: Iris Tang, MBBS, MRCP (she/her/hers) – Department of Medicine, LKS Faculty of Medicine, University of Hong Kong
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1157: Experience of Pain in Adults with Idiopathic Inflammatory Myopathies, Myositis
    Location: Poster Hall
    Abstract Poster Presenter: Helene Alexanderson, PhD, PT – Karolinska University Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1158: Dermatomyositis Flares After COVID-19 Vaccination and/or SARS-CoV-2 Infection
    Location: Poster Hall
    Abstract Poster Presenter: Maximiliano Diaz Menindez, MD (he/him/his) – Mayo Clinic
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1159: Expanded Cytotoxic CD8+ T Cell Clones Characterize the Blood of Inclusion Body Myositis Patients
    Location: Poster Hall
    Abstract Poster Presenter: Lorien Shakib, BSc – Weill Cornell Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1160: Antibody Predictors of Prognosis in a Large Multi-centre Cohort of Idiopathic Inflammatory Myopathy Associated Interstitial Lung Disease
    Location: Poster Hall
    Abstract Poster Presenter: James Galloway, MBBS – King's College London
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1161: Proteasome Inhibitor Repurposed for Dermatomyositis: Results of a Drug Repurposing Analysis Based on the Transcriptomic Signature of Patients' Perifascicular Fibers Validated in Pre-clinical Models
    Location: Poster Hall
    Abstract Poster Presenter: Maude Bouchard Marmen, MD – CHU de Quebec Université Laval
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1162: Serial Imaging Changes in Skeletal Muscle Composition and Their Association with Clinical Outcomes in Idiopathic Inflammatory Myopathies
    Location: Poster Hall
    Abstract Poster Presenter: Christina Mariaselvam, PhD – Jawaharlal Institute of Postgraduate Medical Education and Research
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1163: Anti-melanoma Differentiation Associated Gene 5 (Anti-MDA5) Antibody Dermatomyositis: Clinical Features and Outcome in a Racially Diverse Patient Cohort
    Location: Poster Hall
    Abstract Poster Presenter: Bibi Ayesha, MD – Montefiore Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1164: Can We Differentiate Patients with Dysferlinopathies and Inflammatory Myopathies by Muscle Ultrasound? A Discriminant Analysis Study
    Location: Poster Hall
    Abstract Poster Presenter: Carlos Pineda, PhD – Instituto Nacional de Rehabilitacion
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1165: Long-term Changes in Lung Function in Melanoma Differentiation-associated Protein 5 (MDA5) Antibody Positive Dermatomyositis Patients: Experience of a Single Center Longitudinal Cohort in North America
    Location: Poster Hall
    Abstract Poster Presenter: Jenice Cheah, MD – UCLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1166: Patients with COVID-19 and Polymyositis Inpatient Outcomes and Hospital Cost: Nationwide Inpatient Sample 2020
    Location: Poster Hall
    Abstract Poster Presenter: Emily He, MD, MS – Loma Linda University Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1167: Transcriptome Analysis of Peripheral Blood Reveals Superiority of the Triple Combination of Baricitinib, Rituximab, and Tacrolimus Therapy (BRT-Tx.) for anti-MDA5 Antibody-positive Dermatomyositis (MDA5-DM)
    Location: Poster Hall
    Abstract Poster Presenter: Yoshinobu Koyama, MD, PhD – Japanese Red Cross Okayama Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1168: Evaluation of Agreement Between Functional and Radiological Changes in Idiopathic Inflammatory Myositis (IIM) Associated Interstitial Lung Disease (ILD)
    Location: Poster Hall
    Abstract Poster Presenter: Sonali Narain, MD, MPH – Northwell Health
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1169: All-cause Mortality and Risk Factors for Death in a Large Multi-center Prospective Registry Cohort of Idiopathic Inflammatory Myositis in China
    Location: Poster Hall
    Abstract Poster Presenter: Liying Peng, PhD – Peking Union Medical College
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1170: Damage Accrual in Idiopathic Inflammatory Myopathies: Data from a Monocentric Cohort and Impact on Patients’ Quality of Life
    Location: Poster Hall
    Abstract Poster Presenter: Marta Mosca, MD, PhD – University of Pisa
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1171: Cardiac Biomarkers Are a Useful Initial Screening Tool for Myocarditis in Patients with Idiopathic Inflammatory Myopathies
    Location: Poster Hall
    Abstract Poster Presenter: Caoilfhionn Connolly, MD, MSc – Galway Clinic
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1172: Relapse Rate After Glucocorticoid-free Remission in Idiopathic Inflammatory Myopathies with Validation of the International Myositis Assessment & Clinical Studies Group (IMACS) Criteria for Remission and Relapse
    Location: Poster Hall
    Abstract Poster Presenter: Hideaki Tsuji, MD, PhD – Division of Rheumatology, Department of Medicine, Karolinska Institutet; Department of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1173: Prognostic Biomarkers and Radiological Features of Idiopathic Inflammatory Myopathy Associated Interstitial Lung Disease
    Location: Poster Hall
    Abstract Poster Presenter: Toshimasa Shimizu, MD, PhD – Nagasaki University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1174: Anti-HMGCR Immune-mediated Necrotising Myopathy: Calculation of Incidence and Confirmation of Low Malignancy Risk in Two Independent Cohorts. a Retrospective Case Review
    Location: Poster Hall
    Abstract Poster Presenter: Thomas Khoo, MBBS (he/him/his) – University of Manchester
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1175: Inclusion of All Myositis Specific Autoantibodies or Other Rashes Leads to Better Sensitivity but Lower Specificity of 2017 EULAR/ACR Myositis Classification Criteria for Dermatomyositis
    Location: Poster Hall
    Abstract Poster Presenter: Yusra Hasan, MD – CHI Health Creighton university medical center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1176: Brepocitinib Prevents Type-I Interferon Induced Damage in Cultured Myocytes and Endothelial Cells Indicating a Potential Role in the Treatment of Dermatomyositis
    Location: Poster Hall
    Abstract Poster Presenter: Jiri Vencovsky, MD (he/him/his) – Institute of Rheumatology
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1177: Anti-HMGCR Autoantibody Levels in the Follow-up of Statin-induced Immune-mediated Necrotizing Myopathy: Multicentric Study of 24 Patients
    Location: Poster Hall
    Abstract Poster Presenter: Cristina Corrales, MD (she/her/hers) – HOSPITAL UNIVERSITARIO MARQUES DE VALDECILLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1178: Self-Perceived Knowledge of Myositis Among Social Media Respondents- a Pilot Study on Twitter
    Location: Poster Hall
    Abstract Poster Presenter: Srijan Mittal, MBBS – Maulana Azad Medical College
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1179: Rituximab in the Treatment of Interstitial Lung Disease Associated with the Antisynthetase Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Javier Narvaez, MD, PhD – Hospital Universitario de Bellvitge
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1180: Machine Learning Approach for the Prediction of anti-MDA5 Positive Dermatomyositis Mortality
    Location: Poster Hall
    Abstract Poster Presenter: Xinlei Liu', MMed – Department of Rheumatology and Immunology, Tianjin Medical University General Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1181: Real-World Myositis Antibody Frequency and Patient Awareness
    Location: Poster Hall
    Abstract Poster Presenter: Raisa Lomanto Silva, MD (she/her/hers) – University of Pittsburgh Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Monday, Nov 13th
    9:00 AM – 11:00 AM PT
    1182: Treatment Trajectories and Patient Outcomes in Idiopathic Inflammatory Myopathies
    Location: Poster Hall
    Abstract Poster Presenter: Kristin Wipfler, PhD (she/her/hers) – FORWARD, The National Databank for Rheumatic Diseases
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    8:30 AM – 9:30 AM PT
    14T112: Flexing Strong Science on Weak Muscles: Genetics, Genomics, and Autoantibodies in Myositis
    Location: Room 25A-C
    Moderator: Janine Lamb, PhD, BSc – University of Manchester, UK
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME: 1 hours
  • Tuesday, Nov 14th
    8:30 AM – 8:45 AM PT
    Cellular and Molecular Hallmarks of MDA5+ Dermatomyositis
    Location: Room 25A-C
    Speaker: Qiong Fu, MD – Renji Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    8:45 AM – 9:00 AM PT
    Genomic Studies Identify Novel Factors Influencing the Development of Myositis
    Location: Room 25A-C
    Speaker: Chris Amos, PhD – Baylor College of Medicine
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 9:15 AM PT
    Autoantibodies and Gene Expression Contributions into the Pathogensis of Myositis
    Location: Room 25A-C
    Speaker: Andrew Mammen, MD, PhD – NIH
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:15 AM – 9:30 AM PT
    Q&A
    Location: Room 25A-C
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    (1945–1972) Muscle Biology, Myositis & Myopathies – Basic & Clinical Science Poster III
    Location: Poster Hall
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1945: Case Series of 6 Patients Exhibiting Myositis as a Rheumatologic Adverse Events Related to Cancer Immunotherapy in Two Spanish Hospitals
    Location: Poster Hall
    Abstract Poster Presenter: Antonio Gomez-Centeno, MD – Parc Taulí Hospital Universitari
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1946: Zetomipzomib Demonstrates Favorable Long-term Safety and Tolerability Profile Without Signs of Immunosuppression: Results from the PRESIDIO Study and Its Open-label Extension Study in Patients with Dermatomyositis and Polymyositis
    Location: Poster Hall
    Abstract Poster Presenter: Rohit Aggarwal, MD, MS – University of Pittsburgh
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1947: National Incidence, Prevalence & Mortality in Idiopathic Inflammatory Myopathies & Associated Interstitial Lung Disease in England
    Location: Poster Hall
    Abstract Poster Presenter: James Galloway, MBBS – King's College London
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1948: The Influence of Specific Myositis Antibodies on the Development of Interstitial Lung Disease
    Location: Poster Hall
    Abstract Poster Presenter: TING-YUAN LAN, MD (he/him/his) – National Taiwan University Hospital Hsinchu Branch
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1949: Relapse of Rapidly Progressive Interstitial Lung Disease in Patients with Anti-Melanoma Differentiation-Associated Gene 5 Autoantibody-Positive Dermatomyositis
    Location: Poster Hall
    Abstract Poster Presenter: Noriko Sasaki, MD – tokai university
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1950: Thromboembolic Risk Associated with Intravenous Immune Globulin Use in Patients with Idiopathic Inflammatory Myopathy: A Large Database Study
    Location: Poster Hall
    Abstract Poster Presenter: Rohan Mehta, DO – Medical College of Wisconsin
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1951: Valid and Reliable Physical Function Tests in Idiopathic Inflammatory Myositis
    Location: Poster Hall
    Abstract Poster Presenter: Tanya Chandra, MBBS – University of Pittsburgh Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1952: Anti-MDA5 Associated Dermatomyositis: Clinical Features and Outcomes in a Predominantly African-American Case Series
    Location: Poster Hall
    Abstract Poster Presenter: David Wang, MD – Emory
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1953: Mortality Trends in Polymyositis and Dermatomyositis in Mexico: A General Population-based Study from 2000 to 2019
    Location: Poster Hall
    Abstract Poster Presenter: Claudia Mendoza-Pinto, MD, PhD (she/her/hers) – Instituto Mexicano del Seguro Social
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1954: Evaluation of Cancer Screening Methods in Patients Diagnosed with Inflammatory Muscle Disease at Kansas University Medical Center
    Location: Poster Hall
    Abstract Poster Presenter: Pooja Bhadbhade, DO, RhMSUS – University of Kansas Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1955: Responsiveness and Minimal Important Difference of PROMIS Pain Interference, Fatigue, and Physical Function Forms in Adults with Idiopathic Inflammatory Myopathies
    Location: Poster Hall
    Abstract Poster Presenter: Didem Saygin, MD – University of Pittsburgh
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1956: Rituximab Treatment in Adult Patients with Idiopathic Inflammatory Myositis (IIM): A Systematic Review and Meta-analysis
    Location: Poster Hall
    Abstract Poster Presenter: Lilian Otalora Rojas, MD – Baptist medical center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1957: Non-Linear Mendelian Randomization Analyses Support a Role for Low Vitamin D Status in Sarcopenia Risk
    Location: Poster Hall
    Abstract Poster Presenter: Tingting Sha, PhD – Hunan Key Laboratory of Joint Degeneration and Injury
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1958: Validity, Responsiveness and Minimal Clinically Important Difference of EQ-5D-5L in Inflammatory Myositis: A Longitudinal Study
    Location: Poster Hall
    Abstract Poster Presenter: Chengappa Kavadichanda, MD, DM – Jawaharlal Institute of Postgraduate Medical Education and Research
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1959: Quantitative Scoring of High Resolution Chest Computed Tomography (HRCT) Images in Myositis and Antisynthetase Syndrome Related Interstitial Lung Disease in Comparison to Scleroderma Related Interstitial Lung Disease
    Location: Poster Hall
    Abstract Poster Presenter: Sangmee Bae, MD, MS – UCLA
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1960: From Clinical Amyopathy to Severe Oropharyngeal Dysphagia in Pure Dermatomyositis: A Greater Extent of Muscle Weakness Is Associated with a Higher Cancer Prevalence
    Location: Poster Hall
    Abstract Poster Presenter: Hao Cheng Shen, MD – University of Montreal
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1961: Anti-PM/Scl Autoantibodies in Juvenile Myositis Are Associated with a Distinct Phenotype Resembling Anti-synthetase Syndrome
    Location: Poster Hall
    Abstract Poster Presenter: Matthew Sherman, MD, MHS – DAIT/NIAID/NIH
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1962: Toll-Like Receptor 7/8 Activation of Immune and Non-Immune Cells in Muscle by RNA-Containing Immune Complexes Can Contribute to Inflammation and the Pathogenesis of Myositis
    Location: Poster Hall
    Abstract Poster Presenter: Yin Wu, BS – EMDSerono
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1963: Effect of JAK-STAT Inhibition by Baricitinib and Tofacitinib on Disease Phenotype in a Mouse Model of Myositis
    Location: Poster Hall
    Abstract Poster Presenter: Rita Spathis, MS (she/her/hers) – Binghamton University School of Pharmacy and Pharmaceutical Sciences
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1964: Penn State Registry of Inflammatory Myopathies (PRIMO) Provides Insights into Disease Features and Co-Morbidity Screening Utilization
    Location: Poster Hall
    Abstract Poster Presenter: Jacob Colello, MD – TE-Penn State MS Hershey Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1965: Discordance Between Patient and Physician Perception of Disease Activity Among Patients with Idiopathic Inflammatory Myopathies: Results from the COVAD Study
    Location: Poster Hall
    Abstract Poster Presenter: Mrinalini Dey, MRCP, MA, MBBCH – Centre for Rheumatic Diseases, King's College London
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1966: Investigating Esophageal Involvement in Anti-Synthetase Syndrome: How to Discover the Submerged?
    Location: Poster Hall
    Abstract Poster Presenter: Marta Mosca, MD, PhD – University of Pisa
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1967: Infectious Myopathies in an Urban Inflammatory Idiopathic Myopathy Cohort: Frequency and Impact on Disease Course and Treatment
    Location: Poster Hall
    Abstract Poster Presenter: Ana Valle, MD, MHS – Brigham and Women's Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1968: Pregnancy Outcomes in Idiopathic Inflammatory Myopathies: A Comparison to the General American Population
    Location: Poster Hall
    Abstract Poster Presenter: Ana Valle, MD, MHS – Brigham and Women's Hospital
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1969: Multimorbidity and PROMIS Health Outcomes in Patients with Idiopathic Inflammatory Myopathies: Analysis from the COVAD Study
    Location: Poster Hall
    Abstract Poster Presenter: Latika Gupta, MD, DM, MRCP – Royal Wolverhampton NHS Trust
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1970: Impaired Health-Related Quality of Life in Patients with Idiopathic Inflammatory Myopathies: A Cross-Sectional Analysis from the COVAD Dataset
    Location: Poster Hall
    Abstract Poster Presenter: Latika Gupta, MD, DM, MRCP – Royal Wolverhampton NHS Trust
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1971: Muscle Pathology in Patients with Primary Biliary Cholangitis
    Location: Poster Hall
    Abstract Poster Presenter: José Milisenda, MD, PhD – Hospital Clínic de Barcelona
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    9:00 AM – 11:00 AM PT
    1972: Evaluation of Myositis Autoantibodies as Predictors of Response to IVIG: Post-hoc Analysis of a Large Randomized, Double-Blind, Placebo-Controlled Phase III Trial
    Location: Poster Hall
    Abstract Poster Presenter: Christina Charles-Schoeman, MD, MS – UCLA Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    2:00 PM – 3:30 PM PT
    14T152: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science I (2461–2466)
    Location: Room 25A-C
    Abstract Moderator: Paul Dellaripa, MD – Brigham and Womens Hospital
    Abstract Moderator: Hanna Kim, MD, MS – NIAMS, NIH
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    2:00 PM – 2:10 PM PT
    2461: Transcriptional Derepression of CHD4/NuRD-regulated Genes in the Muscle of Patients with Dermatomyositis and anti-Mi2 Autoantibodies
    Location: Room 25A-C
    Presenting Author: Iago Pinal-Fernandez, MD, PhD – National Institutes of Health
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    2:15 PM – 2:25 PM PT
    2462: Mitochondrial-Mediated Neutrophil Activation in Dermatomyositis (DM) and Inclusion Body Myositis (IBM): Insights into Pathogenesis and Therapeutic Implications
    Location: Room 25A-C
    Presenting Author: Jorge Gonzalez Chapa, MD, PhD – University of Washington
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    2:30 PM – 2:40 PM PT
    2463: Efficacy and Safety of Car-T-Cell Treatment in Refractory Antisynthetase Syndrome – Data of the First Three Patients
    Location: Room 25A-C
    Presenting Author: Jule Taubmann, MD, BSc – Universitätsklinikum Erlangen
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    2:45 PM – 2:55 PM PT
    2464: B Cells in Anti-tRNA Synthetase Syndrome Patients Show an Activated, Interferon Responsive Signature
    Location: Room 25A-C
    Presenting Author: Erin Wilfong, MD, PhD (she/her/hers) – Vanderbilt University Medical Center
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    3:00 PM – 3:10 PM PT
    2465: Clonally Expanded B Cells in Anti-Histidyl-tRNA Synthetase Syndrome Patients Exhibit an Autoreactive-Prone Memory Phenotype and Bind Jo-1 Autoantigen
    Location: Room 25A-C
    Presenting Author: Lindsay Bass, BS (she/her/hers) – Vanderbilt University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    3:15 PM – 3:25 PM PT
    2466: Monoclonal Anti-MDA5 Autoantibodies Derived from a Patient with Dermatomyositis Target the Hel2i Domain of the MDA5 Protein
    Location: Room 25A-C
    Presenting Author: Eveline Van Gompel, MSc – KU Leuven - Karolinska Institutet
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    4:00 PM – 5:00 PM PT
    14T164: Myositis Pearls for Diagnosis and Management
    Location: Ballroom 20D
    Moderator: Jemima Albayda, MD, RhMSUS – Johns Hopkins University
    Moderator: Didem Saygin, MD – University of Pittsburgh
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
     CME: 1 hours
  • Tuesday, Nov 14th
    4:00 PM – 4:15 PM PT
    Pearls in Myositis Diagnosis and Evaluation
    Location: Ballroom 20D
    Speaker: Hector Chinoy, PhD, MBBS, MSc, FRCP – The University of Manchester
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    4:15 PM – 4:30 PM PT
    Atypical Presentations of Myositis
    Location: Ballroom 20D
    Speaker: Elie Naddaf, MD – Mayo Clinic
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    4:30 PM – 4:45 PM PT
    Tips and Tricks in Myositis Treatment
    Location: Ballroom 20D
    Speaker: Lisa Christopher-Stine, MD, MPH – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Tuesday, Nov 14th
    4:45 PM – 5:00 PM PT
    Q&A
    Location: Ballroom 20D
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Wednesday, Nov 15th
    9:15 AM – 10:45 AM PT
    15W118: Abstracts: Muscle Biology, Myositis & Myopathies – Basic & Clinical Science II (2575–2580)
    Location: Room 23A-C
    Abstract Moderator: Erin Wilfong, MD, PhD (she/her/hers) – Vanderbilt University Medical Center
    Abstract Moderator: Lisa Christopher-Stine, MD, MPH – Johns Hopkins University
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Wednesday, Nov 15th
    9:15 AM – 9:25 AM PT
    2575: Accurate Stratification of Cancer Risk in a Real-World Cohort Using the International Guideline for Idiopathic Inflammatory Myopathy-Associated Cancer Screening
    Location: Room 23A-C
    Presenting Author: Alexander Oldroyd, PhD, MSc, MBChB, MRCP – University of Manchester
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Wednesday, Nov 15th
    9:30 AM – 9:40 AM PT
    2576: Rapid Onset of Response in Adult Dermatomyositis Patients Receiving Anti-interferon β (PF-06823859): Results of a Phase 2, Double-blind, Randomized, Placebo-Controlled Study
    Location: Room 23A-C
    Presenting Author: Rohit Aggarwal, MD, MS – University of Pittsburgh
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Wednesday, Nov 15th
    9:45 AM – 9:55 AM PT
    2577: Frequency of Atherosclerotic Cardiovascular Disease Following a Diagnosis of Idiopathic Inflammatory Myopathy: Data from a Large National Registry
    Location: Room 23A-C
    Presenting Author: Astia Allenzara, MD – UNC
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Wednesday, Nov 15th
    10:00 AM – 10:10 AM PT
    2578: Machine Learning Identifies New Sporadic Inclusion Body Myositis Endotypes Associated with Unique Autoantibody Profiles
    Location: Room 23A-C
    Presenting Author: Jing Yi Wei, BS, MSc – University of Toronto
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Wednesday, Nov 15th
    10:15 AM – 10:25 AM PT
    2579: Validation of PROMIS in Adult and Pediatric Patients with Idiopathic Inflammatory Myopathies
    Location: Room 23A-C
    Presenting Author: Emma Austenfeld, MD, MPH – Medical College of Wisconsin
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)
  • Wednesday, Nov 15th
    10:30 AM – 10:40 AM PT
    2580: High-intensity Resistance Training Improves Quality of Life, Muscle Endurance and Strength in Patients with Myositis
    Location: Room 23A-C
    Presenting Author: Kasper Yde Jensen, MSc – Copenhagen University Hospital - Rigshospitalet
    Myopathic rheumatic diseases (polymyositis, dermatomyositis, inclusion body myositis)